QUAY STEVEN C — SEC Form 4 filings

SEC reporting owner CIK 1008227. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-31.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-07-01 to 2026-03-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ATOSSA THERAPEUTICS, INC. (ATOS)President & CEO, Director61 leg · 11,239 sh · $9,8877

Form 4 filings — QUAY STEVEN C

FiledFormIssuerReported transactionsSource
2026-03-314ATOSSA THERAPEUTICS, INC. (ATOS)Grant/award (A): 65,000 @ $0EDGAR
2026-01-304/AATOSSA THERAPEUTICS, INC. (ATOS)Grant/award (A): 331,674 @ $0 · Grant/award (A): 950,000 (derivative) @ $0.60EDGAR
2026-01-224ATOSSA THERAPEUTICS, INC. (ATOS)Grant/award (A): 325,203 @ $0 · Grant/award (A): 950,000 (derivative) @ $0.60EDGAR
2025-05-224ATOSSA THERAPEUTICS, INC. (ATOS)Purchase (P): 11,239 @ $0.88EDGAR
2025-05-164ATOSSA THERAPEUTICS, INC. (ATOS)Grant/award (A): 1,366,062 (derivative) @ $0EDGAR
2024-07-014ATOSSA THERAPEUTICS, INC. (ATOS)Grant/award (A): 1,795,100 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1008227 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →